Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An MG53-IRS1-interaction disruptor ameliorates insulin resistance.
Park JS, Lee H, Choi BW, Ro S, Lee D, Na JE, Hong JH, Lee JS, Kim BW, Ko YG. Park JS, et al. Among authors: ro s. Exp Mol Med. 2018 Jun 6;50(6):1-12. doi: 10.1038/s12276-018-0099-9. Exp Mol Med. 2018. PMID: 29884820 Free PMC article.
A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
Jeong HW, Lee JW, Kim WS, Choe SS, Shin HJ, Lee GY, Shin D, Lee JH, Choi EB, Lee HK, Yon GH, Cho B, Kim HR, Choi SH, Chung YS, Park SB, Chung H, Ro S, Kim JB. Jeong HW, et al. Among authors: ro s. Mol Pharmacol. 2010 Nov;78(5):877-85. doi: 10.1124/mol.110.065748. Epub 2010 Aug 19. Mol Pharmacol. 2010. PMID: 20724462
A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma.
Jeong HW, Lee JW, Kim WS, Choe SS, Kim KH, Park HS, Shin HJ, Lee GY, Shin D, Lee H, Lee JH, Choi EB, Lee HK, Chung H, Park SB, Park KS, Kim HS, Ro S, Kim JB. Jeong HW, et al. Among authors: ro s. Diabetes. 2011 Feb;60(2):496-506. doi: 10.2337/db09-1145. Diabetes. 2011. PMID: 21270261 Free PMC article.
Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
Woo JK, Kang JH, Jang YS, Ro S, Cho JM, Kim HM, Lee SJ, Oh SH. Woo JK, et al. Among authors: ro s. Oncol Rep. 2015 Apr;33(4):1947-55. doi: 10.3892/or.2015.3793. Epub 2015 Feb 10. Oncol Rep. 2015. PMID: 25672292
408 results